Premium
Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome
Author(s) -
Choi Charles,
Moller Daniel,
Tan Julia,
Dou Carol,
Peterson Erica A.,
Medvedev Nadia,
Dutz Jan P,
Carruthers Mollie N.,
Chen Luke Y. C.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16332
Subject(s) - medicine , alpha interferon , gastroenterology , discontinuation , immunology , methotrexate , hypereosinophilic syndrome , population , interferon , eosinophilia , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom